{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:58:05Z","timestamp":1781647085102,"version":"3.54.5"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:00:00Z","timestamp":1775520000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T00:00:00Z","timestamp":1779062400000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001807","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de S\u00e3o Paulo","doi-asserted-by":"publisher","award":["2018\/18932-0"],"award-info":[{"award-number":["2018\/18932-0"]}],"id":[{"id":"10.13039\/501100001807","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Brain-derived neurotrophic factor (BDNF) has emerged as a key regulator of neuronal plasticity in the central nervous system. Successful biological interventions upregulate the expression of BDNF in generalized anxiety disorder (GAD) patients, but no study of psychological treatments has been found. The present study aimed to evaluate changes in plasma BDNF levels following two psychological treatments with established clinical efficacy in patients with GAD. Methods: Participants were recruited for a 14-week, 10-session clinical trial of either group acceptance-based behavior therapy (ABBT) or supportive therapy (ST). Eligible patients were GAD patients aged 18\u201365 years. Plasma BDNF was measured in 82 patients before and after the intervention (ABBT\u2009=\u200941, ST\u2009=\u200941). Correlation with anxiety symptom severity was also assessed using the Hamilton Anxiety Scale at pre- and post-treatment. Results: BDNF increased in both groups over time (ST: difference\u2009=\u20092042.6, t\u2009=\u20094.81,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001 vs. ABBT: difference\u2009=\u20091947.8, t\u2009=\u20094.46,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Although anxiety symptoms decreased in both groups, no correlation between BDNF and anxiety severity was found. Conclusions: The present study suggests that a short-term trial of two clinically effective psychotherapeutic interventions was associated with increases in plasma BDNF levels in GAD patients. Given the absence of associations between BDNF changes and symptom severity, these findings should be interpreted cautiously and not as evidence of treatment-specific or mechanistic effects.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>\n                      NCT03930095||\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/www.clinicaltrials.gov\" ext-link-type=\"uri\">https:\/\/www.clinicaltrials.gov<\/jats:ext-link>\n                      \/ retrospectively registered on 15 April 2019.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12888-026-08027-8","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T07:49:51Z","timestamp":1775548191000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Increased brain-derived neurotrophic factor following successful psychological treatment in generalized anxiety disorder: a randomized clinical trial"],"prefix":"10.1186","volume":"26","author":[{"given":"Lucas","family":"Gandarela","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiago P. de A.","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Mar\u00e7al","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel A.","family":"Burdmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco Lotufo","family":"Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcio A.","family":"Bernik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,7]]},"reference":[{"issue":"2","key":"8027_CR1","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pneurobio.2005.06.003","volume":"76","author":"CR - Bramham","year":"2005","unstructured":"Bramham CR, Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog Neurobiol. 2005;76(2):99\u2013125. https:\/\/doi.org\/10.1016\/j.pneurobio.2005.06.003.","journal-title":"Prog Neurobiol"},{"issue":"1","key":"8027_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/nrn3379","volume":"14","author":"H - Park","year":"2013","unstructured":"Park H, Poo MM. Neurotrophin regulation of neural circuit development and function. Nat Rev Neurosci. 2013;14(1):7\u201323. https:\/\/doi.org\/10.1038\/nrn3379.","journal-title":"Nat Rev Neurosci"},{"issue":"12","key":"8027_CR3","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","volume":"59","author":"RS - Duman","year":"2006","unstructured":"Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol Psychiatry. 2006;59(12):1116\u201327. https:\/\/doi.org\/10.1016\/j.biopsych.2006.02.013.","journal-title":"Biol Psychiatry"},{"key":"8027_CR4","doi-asserted-by":"publisher","first-page":"55","DOI":"10.3389\/fnint.2013.00055","volume":"7","author":"S - Suliman","year":"2013","unstructured":"Suliman S, Hemmings SMJ, Seedat S. Brain-derived neurotrophic factor (BDNF) protein levels in anxiety disorders: systematic review and meta-regression analysis. Front Integr Neurosci. 2013;7:55. https:\/\/doi.org\/10.3389\/fnint.2013.00055.","journal-title":"Front Integr Neurosci"},{"issue":"6","key":"8027_CR5","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1017\/S0033291706007367","volume":"36","author":"JM - Hettema","year":"2006","unstructured":"Hettema JM, Kuhn JW, Prescott CA, Kendler KS. The impact of generalized anxiety disorder and stressful life events on risk for major depressive episodes. Psychol Med. 2006;36(6):789\u201395.","journal-title":"Psychol Med"},{"key":"8027_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.pnpbp.2013.01.002","volume":"43","author":"S - Ball","year":"2013","unstructured":"Ball S, Marangell LB, Lipsius S, Russell JM. Brain-derived neurotrophic factor in generalized anxiety disorder: results from a duloxetine clinical trial. Prog Neuropsychopharmacol Biol Psychiatry. 2013;43:217\u201321. https:\/\/doi.org\/10.1016\/j.pnpbp.2013.01.002.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"8027_CR7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.neulet.2018.07.008","volume":"684","author":"R - Lu","year":"2018","unstructured":"Lu R, Zhang C, Liu Y, Wang L, Chen X, Zhou X. The effect of bilateral low-frequency rTMS over dorsolateral prefrontal cortex on serum brain-derived neurotropic factor and serotonin in patients with generalized anxiety disorder. Neurosci Lett. 2018;684:67\u201371. https:\/\/doi.org\/10.1016\/j.neulet.2018.07.008.","journal-title":"Neurosci Lett"},{"issue":"1","key":"8027_CR8","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.pnpbp.2006.09.006","volume":"31","author":"MC Jockers-Scher\u00fcbl","year":"2007","unstructured":"Jockers-Scher\u00fcbl MC, Zubraegel D, Baer T, Linden M, Danker-Hopfe H, Schulte-Herbr\u00fcggen O, et al. Nerve growth factor serum concentrations rise after successful cognitive-behavioural therapy of generalized anxiety disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2007;31(1):200\u20134. https:\/\/doi.org\/10.1016\/j.pnpbp.2006.09.006.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6","key":"8027_CR9","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1037\/a0012720","volume":"76","author":"L - Roemer","year":"2008","unstructured":"Roemer L, Orsillo SM, Salters-Pedneault K. Efficacy of an acceptance-based behavior therapy for generalized anxiety disorder: evaluation in a randomized controlled trial. J Consult Clin Psychol. 2008;76(6):1083\u20139. https:\/\/doi.org\/10.1037\/a0012720.","journal-title":"J Consult Clin Psychol"},{"issue":"5","key":"8027_CR10","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1037\/a0032871","volume":"81","author":"SA Hayes-Skelton","year":"2013","unstructured":"Hayes-Skelton SA, Roemer L, Orsillo SM. A randomized clinical trial comparing an acceptance-based behavior therapy to applied relaxation for generalized anxiety disorder. J Consult Clin Psychol. 2013;81(5):761\u201373. https:\/\/doi.org\/10.1037\/a0032871.","journal-title":"J Consult Clin Psychol"},{"issue":"4","key":"8027_CR11","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.cpr.2012.01.003","volume":"32","author":"P - Cuijpers","year":"2012","unstructured":"Cuijpers P, Driessen E, Hollon SD, van Oppen P, Barth J, Andersson G. The efficacy of non-directive supportive therapy for adult depression: a meta-analysis. Clin Psychol Rev. 2012;32(4):280\u201391. https:\/\/doi.org\/10.1016\/j.cpr.2012.01.003.","journal-title":"Clin Psychol Rev"},{"key":"8027_CR12","doi-asserted-by":"publisher","unstructured":"Hunot V, Churchill R, Silva de Lima M, Teixeira V. Psychological therapies for generalised anxiety disorder. Cochrane Database Syst Ver. 2007;(1):1CD001848. https:\/\/doi.org\/10.1002\/14651858.CD001848.","DOI":"10.1002\/14651858.CD001848"},{"key":"8027_CR13","doi-asserted-by":"publisher","unstructured":"De Almeida Sampaio TP, Jorge RC, Martins DS, Gandarela LM, Hayes-Skelton S, Bernik MA, et al. Efficacy of an acceptance-based group behavioral therapy for generalized anxiety disorder. Depress Anxiety. 2020;37(12):1179\u201393. https:\/\/doi.org\/10.1002\/da.23021.","DOI":"10.1002\/da.23021"},{"issue":"Suppl 20","key":"8027_CR14","first-page":"22","volume":"59","author":"DV - Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22\u201333. PMID: 9881538.","journal-title":"J Clin Psychiatry"},{"issue":"4","key":"8027_CR15","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0197-2456(88)90047-5","volume":"9","author":"JP - Matts","year":"1988","unstructured":"Matts JP, Lachin JM. Properties of permuted-block randomization in clinical trials. Control Clin Trials. 1988;9(4):327\u201344. https:\/\/doi.org\/10.1016\/0197-2456(88)90047-5.","journal-title":"Control Clin Trials"},{"issue":"3","key":"8027_CR16","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1176\/appi.focus.12.3.285","volume":"12","author":"JC - Markowitz","year":"2014","unstructured":"Markowitz JC. What is supportive therapy? Focus. 2014;12(3):285\u20139. https:\/\/doi.org\/10.1176\/appi.focus.12.3.285.","journal-title":"Focus"},{"issue":"4","key":"8027_CR17","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1590\/S0004-282X2010000400005","volume":"68","author":"A - Kummer","year":"2010","unstructured":"Kummer A, Cardoso F, Teixeira AL. Generalized anxiety disorder and the Hamilton Anxiety Rating Scale in Parkinson\u2019s disease. Arq Neuropsiquiatr. 2010;68(4):495\u2013501. https:\/\/doi.org\/10.1590\/S0004-282X2010000400005.","journal-title":"Arq Neuropsiquiatr"},{"issue":"1","key":"8027_CR18","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1111\/j.2044-8341.1959.tb00467.x","volume":"32","author":"M - Hamilton","year":"1959","unstructured":"Hamilton M. The assessment of anxiety states by rating. Br J Med Psychol. 1959;32(1):50\u20135. https:\/\/doi.org\/10.1111\/j.2044-8341.1959.tb00467.x.","journal-title":"Br J Med Psychol"},{"key":"8027_CR19","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.jad.2013.10.031","volume":"155","author":"RC - Vignola","year":"2014","unstructured":"Vignola RC, Tucci AM. Adaptation and validation of the depression, anxiety and stress scale (DASS) to Brazilian Portuguese. J Affect Disord. 2014;155:104\u20139. https:\/\/doi.org\/10.1016\/j.jad.2013.10.031.","journal-title":"J Affect Disord"},{"issue":"3","key":"8027_CR20","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/0005-7967(94)00075-u","volume":"33","author":"PF - Lovibond","year":"1995","unstructured":"Lovibond PF, Lovibond SH. The structure of negative emotional states: comparison of the depression anxiety stress scales (DASS) with the beck depression and anxiety inventories. Behav Res Ther. 1995;33(3):335\u201343. https:\/\/doi.org\/10.1016\/0005-7967(94)00075-u.","journal-title":"Behav Res Ther"},{"issue":"2","key":"8027_CR21","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA - Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2013a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inf. 2009;42(2):377\u201381. https:\/\/doi.org\/10.1016\/j.jbi.2008.08.010.","journal-title":"J Biomed Inf"},{"issue":"4","key":"8027_CR22","first-page":"224","volume":"8","author":"E Rankin","year":"1965","unstructured":"Rankin E, Tracy R. Residual gain as a measure of individual difference in a Reading Improvement. J Read. 1965;8(4):224\u201333. https:\/\/www.jstor.org\/stable\/40009364.","journal-title":"J Read"},{"issue":"1","key":"8027_CR23","doi-asserted-by":"publisher","first-page":"40","DOI":"10.7326\/M17-0046","volume":"167","author":"I - Boutron","year":"2017","unstructured":"Boutron I, Altman DG, Moher D, Schulz KF, Ravaud P, CONSORT NPT Group. CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts. Ann Intern Med. 2017;167(1):40\u20137. https:\/\/doi.org\/10.7326\/M17-0046.","journal-title":"Ann Intern Med"},{"issue":"5","key":"8027_CR24","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.pnpbp.2005.04.010","volume":"29","author":"K - Kobayashi","year":"2005","unstructured":"Kobayashi K, Shimizu E, Hashimoto K, Mitsumori M, Koike K, Okamura N, et al. Serum brain-derived neurotrophic factor (BDNF) levels in patients with panic disorder: as a biological predictor of response to group cognitive behavioral therapy. Prog Neuropsychopharmacol Biol Psychiatry. 2005;29(5):658\u201363. https:\/\/doi.org\/10.1016\/j.pnpbp.2005.04.010.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"8027_CR25","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.eurpsy.2003.11.012","volume":"19","author":"P - Gorwood","year":"2004","unstructured":"Gorwood P. Generalized anxiety disorder and major depressive disorder comorbidity: an example of genetic pleiotropy? Eur Psychiatry. 2004;19(1):27\u201333. https:\/\/doi.org\/10.1016\/j.eurpsy.2003.11.012.","journal-title":"Eur Psychiatry"},{"key":"8027_CR26","doi-asserted-by":"publisher","unstructured":"Bhang SY, Kim K, Choi SW, Ahn JH. Do levels of brain-derived neurotrophic factor (BDNF) in plasma correlate with psychopathology in healthy subjects? Neuroscienceletters. 2012;512(2):72\u201377. https:\/\/doi.org\/10.1016\/j.neulet.2012.01.012.","DOI":"10.1016\/j.neulet.2012.01.012"},{"issue":"3","key":"8027_CR27","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1017\/S1461145710000738","volume":"14","author":"AB - Klein","year":"2011","unstructured":"Klein AB, Williamson R, Santini MA, Clemmensen C, Ettrup A, Rios M, Knudsen GM, Aznar S. Blood BDNF concentrations reflect brain-tissue BDNF levels across species. Int J Neuropsychopharmacol. 2011;14(3):347\u201353. https:\/\/doi.org\/10.1017\/S1461145710000738.","journal-title":"Int J Neuropsychopharmacol"},{"key":"8027_CR28","doi-asserted-by":"publisher","first-page":"445","DOI":"10.3389\/fpsyt.2020.00445","volume":"11","author":"FCA - Claudino","year":"2020","unstructured":"Claudino FCA, Gon\u00e7alves L, Schuch FB, Martins HRS, da Rocha NS. The effects of individual psychotherapy in BDNF levels of patients with mental disorders: a systematic review. Front Psychiatry. 2020;11:445. https:\/\/doi.org\/10.3389\/fpsyt.2020.00445.","journal-title":"Front Psychiatry"},{"issue":"5","key":"8027_CR29","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1080\/07420520802387773","volume":"25","author":"A - Piccinni","year":"2008","unstructured":"Piccinni A, Marazziti D, Del Debbio A, Bianchi C, Roncaglia I, Mannari C, et al. Diurnal variation of plasma brain-derived neurotrophic factor (BDNF) in humans: an analysis of sex differences. Chronobiol Int. 2008;25(5):819\u201326. https:\/\/doi.org\/10.1080\/07420520802387773.","journal-title":"Chronobiol Int"},{"issue":"1","key":"8027_CR30","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.neulet.2007.05.064","volume":"423","author":"TS - Kim","year":"2007","unstructured":"Kim TS, Kim DJ, Lee H, Kim YK. Increased plasma brain-derived neurotrophic factor levels in chronic smokers following unaided smoking cessation. Neurosci Lett. 2007;423(1):53\u20137. https:\/\/doi.org\/10.1016\/j.neulet.2007.05.064.","journal-title":"Neurosci Lett"},{"issue":"5","key":"8027_CR31","first-page":"533","volume":"61","author":"JA - Zoladz","year":"2010","unstructured":"Zoladz JA, Pilc A. The effect of physical activity on brain-derived neurotrophic factor: from animal to human studies. J Physiol Pharmacol. 2010;61(5):533\u201341. PMID:21081796.","journal-title":"J Physiol Pharmacol"},{"issue":"4","key":"8027_CR32","doi-asserted-by":"publisher","first-page":"241","DOI":"10.3109\/09513590.2011.613969","volume":"28","author":"N - Russo","year":"2012","unstructured":"Russo N, Russo M, Daino D, Bucci F, Pluchino N, Casarosa E, et al. Polycystic ovary syndrome: brain-derived neurotrophic factor (BDNF) plasma and follicular fluid levels. Gynecol Endocrinol. 2012;28(4):241\u20134. https:\/\/doi.org\/10.3109\/09513590.2011.613969.","journal-title":"Gynecol Endocrinol"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12888-026-08027-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08027-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-026-08027-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T21:34:28Z","timestamp":1781645668000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12888-026-08027-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,7]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8027"],"URL":"https:\/\/doi.org\/10.1186\/s12888-026-08027-8","relation":{},"ISSN":["1471-244X"],"issn-type":[{"value":"1471-244X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,7]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted under the Declaration of Helsinki and Ethical Guidelines for Clinical Studies and was approved by the research ethics committee of the University of S\u00e3o Paulo (USP) Medical School, Brazil (CAPPesq). All participants provided written informed consent for the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"396"}}